IEEE Spectrum on MSN
At-home brain stimulation for depression is just the start
Flow’s headset is the first tDCS device approved by the FDA ...
A noninvasive, home-based brain treatment with transcranial direct current stimulation (tDCS) can reduce pain severity, improve pain-related disability, and enhance endogenous pain modulation in women ...
The FDA has approved the first at -home brain-stimulation device for adults with major depressive disorder (MDD). The FL-100 transcranial direct-current stimulation (tDCS) system (Flow Neuroscience) ...
The at-home brain stimulation device is expected to be available in the second quarter of 2026. The Food and Drug Administration (FDA) has cleared Flow, a prescription home-based cranial ...
News Medical on MSN
Research reveals dual impact of brain stimulation on people with depression and anxiety
Research investigating the effects of transcranial direct current stimulation (tDCS) on individuals with depression and ...
A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study. A device that delivers direct stimulation to ...
In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved the first at-home brain-stimulation device to treat moderate to severe major ...
Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in treating depression, a regulatory milestone that could reshape a mental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results